Treatment of Donor Cells with Oxidative Phosphorylation Inhibitor CPI Enhances Porcine Cloned Embryo Development.

Autor: Cao, Jinping^1,2,3,4,5,6 (AUTHOR) caojinping2021@scau.edu.cn, Dong, Yazheng^1,2,3,4,5,6 (AUTHOR) dongyazheng@stu.scau.edu.cn, Li, Zheng^1,2,3,4,5,6 (AUTHOR) lizheng2022@stu.scau.edu.cn, Wang, Shunbo^1,2,3,4,5,6 (AUTHOR) 03028301@stu.scau.edu.cn, Wu, Zhenfang^1,2,3,4,5,6 (AUTHOR) wzfemail@163.com, Zheng, Enqin^1,2,3,4,5,6 (AUTHOR) eqzheng@scau.edu.cn, Li, Zicong^1,2,3,4,5,6 (AUTHOR) eqzheng@scau.edu.cn

Publikováno v: Animals (2076-2615). May2024, Vol. 14 Issue 9, p1362. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SCCmec transformation requires living donor cells in mixed biofilms

Autor: Mais Maree, Yuri Ushijima, Pedro B. Fernandes, Masato Higashide, Kazuya Morikawa

Publikováno v: Biofilm, Vol 7, Iss , Pp 100184- (2024)

Methicillin-resistant Staphylococcus aureus (MRSA) is an important human pathogen that has emerged through the horizontal acquisition of the staphylococcal cassette chromosome mec (SCCmec). Previously, we showed that SCCmec from heat-killed donors ca

Externí odkaz: https://doaj.org/article/e4f94c8bd21c44a4964f9aa4f07e1794

Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.

Autor: Sáez-Cirión A; Viral Reservoirs and Immune Control Unit, Université Paris Cité, Institut Pasteur, Paris, France. asier.saez-cirion@pasteur.fr.; HIV Inflammation and Persistence Unit, Université Paris Cité, Institut Pasteur, Paris, France. asier.saez-cirion@pasteur.fr., Mamez AC; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., Avettand-Fenoel V; Institut Cochin-CNRS 8104/INSERM U1016/Université de Paris, Paris, France.; LI2RSO, Université d'Orléans, Orléans, France.; Virologie, CHU d'Orléans, Orléans, France., Nabergoj M; Institut Central des Hôpitaux, Sion, Switzerland., Passaes C; Viral Reservoirs and Immune Control Unit, Université Paris Cité, Institut Pasteur, Paris, France.; HIV Inflammation and Persistence Unit, Université Paris Cité, Institut Pasteur, Paris, France., Thoueille P; Service of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Service of Clinical Pharmacology, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Decosterd L; Service of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Hentzien M; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland., Perdomo-Celis F; HIV Inflammation and Persistence Unit, Université Paris Cité, Institut Pasteur, Paris, France., Salgado M; IrsiCaixa, Badalona, Spain.; Germans Trias i Pujol Research Institute, Badalona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Nijhuis M; Translational Virology Research Group, Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.; HIV Pathogenesis Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Mélard A; Institut Cochin-CNRS 8104/INSERM U1016/Université de Paris, Paris, France., Gardiennet E; Institut Cochin-CNRS 8104/INSERM U1016/Université de Paris, Paris, France., Lorin V; Humoral Immunology Unit, Inserm U1222, Université Paris Cité, Institut Pasteur, Paris, France., Monceaux V; Viral Reservoirs and Immune Control Unit, Université Paris Cité, Institut Pasteur, Paris, France.; HIV Inflammation and Persistence Unit, Université Paris Cité, Institut Pasteur, Paris, France., Chapel A; Viral Reservoirs and Immune Control Unit, Université Paris Cité, Institut Pasteur, Paris, France.; HIV Inflammation and Persistence Unit, Université Paris Cité, Institut Pasteur, Paris, France., Gourvès M; Viral Reservoirs and Immune Control Unit, Université Paris Cité, Institut Pasteur, Paris, France., Lechartier M; Viral Reservoirs and Immune Control Unit, Université Paris Cité, Institut Pasteur, Paris, France., Mouquet H; Humoral Immunology Unit, Inserm U1222, Université Paris Cité, Institut Pasteur, Paris, France., Wensing A; Translational Virology Research Group, Department of Global Public Health & Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Martinez-Picado J; IrsiCaixa, Badalona, Spain.; Germans Trias i Pujol Research Institute, Badalona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; UVic-UCC, Vic, Spain.; ICREA, Barcelona, Spain., Yerly S; Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland., Rougemont M; Unaffiliated, Geneva, Switzerland., Calmy A; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. alexandra.calmy@hug.ch.

Publikováno v: Nature medicine [Nat Med] 2024 Sep 02. Date of Electronic Publication: 2024 Sep 02.

Impact of co-transfer of embryos produced by somatic cell nuclear transfer using two types of donor cells on pregnancy outcomes in dogs.

Autor: Young-Bum Son^1,2, Yeon Ik Jeong^1,2, Yeon Woo Jeong^1,3, Hossein, Mohammad Shamim^1,2, Woo Suk Hwang^1,2,4 hwangws@adbrf.org

Publikováno v: Animal Bioscience. Sep2022, Vol. 35 Issue 9, p1360-1366. 7p.